How Prepared Are We For Avian Influenza?
When it comes to public health, and the idea of being prepared for a potential outbreak or pandemic, there are some objective measures that can be put into place including stockpiling vaccines and therapies, having emergency plans, and carrying out surveillance measures to name a few. The federal government, for example, is working to make […]
Executive Function Impairments in Long COVID Linked to Brain Changes
Image symbolizing coronavirus affects the brain. Image credits: Unsplash Long COVID affects millions of individuals worldwide, with symptoms persisting for more than 12 weeks after the initial infection. Among the various challenges faced by patients, cognitive impairments, particularly in executive function (EF), are emerging as significant barriers to daily living. A recent systematic review in […]
Rezafungin is Noninferior to Caspofungin For All-Cause Mortality in Treating Candida Infections
If left unmitigated, Candida can penetrate deeply into the body and develop into fungal infections, including candidemia and invasive candidiasis. These fungal infections can affect the bloodstream and internal organs. Candidemia, in particular, is a common infection found in hospitalized patients. In addition, there are some specific clinical challenges associated with them. “There’s really 2 […]
CARB-X Funds $3.5M to Melio for Rapid Neonatal Sepsis Diagnostic
Erin Duffy, chief of R&D at CARB-X Image credits: LinkedIn The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has awarded a $3.5 million grant to Melio, a biotechnology company, to develop a rapid diagnostic tool to detect neonatal sepsis. This funding will help Melio advance its diagnostic platform, which integrates molecular and microfluidic technologies to identify […]
Early Release – Global Epidemiology of Outbreaks of Unknown Cause Identified by Open-Source Intelligence, 2020–2022 – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: The University of New South Wales, Sydney, New South Wales, Australia (D. Honeyman, D. Gurdasani, A. Notaras, Z. Akhtar, J. Edgeworth, A. Moa, A.A. Chughtai, […]
Early Release – Arbovirus Epidemics as Global Health Imperative, Africa, 2023 – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Gamal Abdel Nasser University, Conakry, Guinea (S.T. Bangoura, A.-K. Keita, M. Diaby, S. Sidibé, K.J.J.O. Kadio, A. Camara, A. Delamou, A. Touré); Centre de Recherche […]
Early Release – Lack of Competence of US Mosquito Species for Circulating Oropouche Virus – Volume 31, Number 3—March 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Wadsworth Center, New York State Department of Health, Slingerlands, New York, USA (A.F. Payne, J. Stout, A.P. Dupuis II, A.T. Ciota); Florida Department of Health, […]
Early Release – Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: University of Oxford, Oxford, UK (J. Bourner, A.P.A. Salam, B.P. Gonçalves, P. Olliaro); Luxembourg Institute of Health, Strassen, Luxembourg (M. Vaillant); Sorbonne Université, Paris, France […]
